STEMETIL prochlorperazine mesilate 12.5 mg/mL Injection ampoule (export)

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

prochlorperazine mesilate, Quantity: 12.5 mg/mL

Pieejams no:

Sanofi-Aventis Australia Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

prochlorperazine mesilate

Zāļu forma:

Injection

Kompozīcija:

Excipient Ingredients: sodium metabisulfite; monoethanolamine; sodium sulfite; water for injections; sodium chloride

Ievadīšanas:

Intramuscular

Vienības iepakojumā:

10 x 1 mL

Receptes veids:

(S1) This Schedule is intentionally blank

Ārstēšanas norādes:

STEMETIL is used in vertigo due to Meniere?s syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.

Produktu pārskats:

Visual Identification: Clear solution, almost colourless or not more than very pale yellow.; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius

Autorizācija statuss:

Licence status A

Autorizācija datums:

2007-07-16